BioLife Solutions Inc (NAS:BLFS)

Q3 2024 BioLife Solutions Inc Earnings Call Transcript

Nov 12, 2024 / 09:30 PM GMT

Release Date Price: $26.5 (-0.38%)

Transcript 10-Q8-K

Key Points

Positve

BioLife Solutions Inc (BLFS) reported its fourth consecutive quarter of sequential revenue growth, with a 43% year-over-year increase in cell processing platform revenue.
The company achieved a significant improvement in adjusted gross margin, reaching 54% in Q3 2024, up from 44% in the same period last year.
BioLife Solutions Inc (BLFS) announced the strategic divestiture of its biostorage business, which is expected to streamline operations and fortify the balance sheet.
The company increased its cell processing revenue guidance for the full year 2024, reflecting strong performance and positive market trends.
BioLife Solutions Inc (BLFS) has a strong market position, with its biopreservation media products embedded in more than 70% of relevant commercially sponsored CGT clinical trials.

Negative

The company reported a GAAP operating loss of $1.6 million for Q3 2024, although this was an improvement from the previous year.
Despite the sale of the biostorage business, BioLife Solutions Inc (BLFS) still faces challenges with its freezer business, which is considered a drag on long-term margins.
The company's total revenue guidance for 2024 was slightly reduced due to a decrease in expected storage revenue following the sale of the biostorage business.
BioLife Solutions Inc (BLFS) is still in the process of exiting its remaining freezer business, which represents less than 13% of sales but impacts long-term profitability.
The company faces potential risks from macroeconomic factors and industry-wide issues that could affect future demand and growth.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BLFS.OQ - Biolife Solutions Inc
Q3 2024 BioLife Solutions Inc Earnings Call
Nov 12, 2024 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon, ladies and gentlemen. And thank you for standing by. Welcome to the BioLife Solutions Q3 2024 shareholder and analyst conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. I will now turn the call over to Troy Wierman, Chief Financial Officer of BioLife Solutions.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you operator. Good afternoon, everyone and thank you for joining the BioLife Solutions 2024 3rd quarter earnings conference call on the call with me

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.